Zhejiang Jolly Pharmaceutical Co.,LTD (SHE:300181)

Market Cap	9.40B -14.7%
Revenue (ttm)	3.11B +14.1%
Net Income	650.37M +19.0%
EPS	0.94 +19.2%
Shares Out	693.22M
PE Ratio	14.48
Forward PE	13.04
Dividend	0.35 (2.46%)
Ex-Dividend Date	May 28, 2026

Volume	8,594,628
Open	14.38
Previous Close	14.22
Day's Range	13.51 - 14.38
52-Week Range	13.52 - 21.07
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About SHE:300181

Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. The company also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1995
• Employees: 2,861
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300181

Financial Performance

In 2025, SHE:300181's revenue was 3.04 billion, an increase of 17.96% compared to the previous year's 2.58 billion. Earnings were 631.93 million, an increase of 24.45%.